Global Chronic Lymphocytic Leukemia Therapeutics Market Research Report to 2027 - Introduction of Novel Therapy Drugs and Availability of Several Pipeline Drugs Presents Opportunities - ResearchAndMarkets.com
16 Jun 2022 18:24 GMT
… drugs and availability of several pipeline drugs
Availability of therapeutics through … , Inc.
Amgen, Inc.
AstraZeneca PLC
Biogen Idec Inc
Boehringer Ingelheim International GmbH …
Biogen stock touches 52-week low at $173.01 amid market challenges
04 Nov 2024 14:56 GMT
Biogen Idec Inc (NASDAQ:BIIB)'s … guidance. The company's pipeline potential peak sales are estimated … to sustainable growth and strategic pipeline expansion.
Biogen's recent …
Anti-Lymphotoxin - Pipeline Insight Report 2018 Featuring Roche, Zydus, Amgen & Biogen Idec - ResearchAndMarkets.com
24 Aug 2018 20:11 GMT
DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The "Anti-Lymphotoxin -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
'Anti-Lymphotoxin - Pipeline Insight, 2018' report offers comprehensive insights …
Antineoplastic Agents (Anticancer Drugs) Research Report 2024: Global Market To Surpass $225 Billion By 2030 - Growing Focus On Rare Cancers And Orphan Drug Development Generates New Opportunities
21 Oct 2024 09:12 GMT
… research, coupled with a robust pipeline of investigational drugs, are ensuring … Mountain Pharmaceutical Baida Pharmaceutical Bayer Biogen Idec BMS Celgene CTTQ Eisai Gilead …
Xenon Pharmaceuticals: Updates To Thesis, Pipeline Progressing
25 Mar 2019 16:16 GMT
… #39;s early stage pipeline was moving forward on … Teva Pharmaceuticals, EMD Serono, Biogen Idec, and Merck) and positioning … 1 preferred stock). Figure 3: Pipeline (Source: corporate presentation) At … its ion channel product pipeline with the addition of …